Page 12 - விரிவான மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விரிவான மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விரிவான மூலதனம் Today - Breaking & Trending Today

The EU and Armenia Comprehensive and Enhanced Partnership Agreement enters into force | EU News


EU News
The EU and Armenia Comprehensive and Enhanced Partnership Agreement enters into force
The European Union-Armenia Comprehensive and Enhanced Partnership Agreement (CEPA) today entered into force. It has now been ratified by the Republic of Armenia, all EU Member States and the European Parliament. This represents an important milestone for EU-Armenia relations.
This Agreement provides a framework for the EU and Armenia to work together in a wide range of areas: strengthening democracy, the rule of law and human rights; creating more jobs and business opportunities, improving legislation, public safety, a cleaner environment, as well as better education and opportunities for research. This bilateral agenda also contributes to overall aim of the EU to deepen and strengthen its relations with the countries of its Eastern neighbourhood through the Eastern Partnership framework. ....

Republic Of Armenia , Partnership Agreement , European Union , European Parliament , European Commission , Eastern Partnership , European Union Armenia Comprehensive , Enhanced Partnership Agreement , Foreign Affairs , குடியரசு ஆஃப் ஆர்மீனியா , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய பாராளுமன்றம் , ஐரோப்பிய தரகு , கிழக்கு கூட்டு , ஐரோப்பிய தொழிற்சங்கம் ஆர்மீனியா விரிவான , வெளிநாட்டு வாழ்க்கைத்தொழில்கள் , கிளிக் செய்க ,

HR resource portal to cover comprehensive training resources


HR resource portal to cover comprehensive training resources
Islamabad
February 28, 2021
Islamabad: The Human Right Resource Portal will cover comprehensive training resources that will provide online material which will be beneficial for human rights practitioners and personnel.
Talking to APP the Secretary Ministry of Human rights informed that training resources would cover a range of topics such as Pakistan’s International Human Rights Obligations and Human Rights Data Collection and Documentation for the benefit of rights practitioner as well as researchers.
He further said that these custom training resources aims at enhancing capacity of the judiciary, prosecution, and law enforcement agencies. ....

Inamullah Khan , Ministry Of Human , European Union , Pakistan International Human Rights Obligations , Ministry Of Human Rights , Human Right Resource Portal , Secretary Ministry , International Human Rights Obligations , Human Rights Data Collection , Human Rights Resource Portal , Human Rights , இனமுள்ளாஹ் காந் , அமைச்சகம் ஆஃப் மனிதன் , ஐரோப்பிய தொழிற்சங்கம் , அமைச்சகம் ஆஃப் மனிதன் உரிமைகள் , மனிதன் சரி வள போர்டல் , செயலாளர் அமைச்சகம் , மனிதன் உரிமைகள் தகவல்கள் சேகரிப்பு , மனிதன் உரிமைகள் வள போர்டல் , மனிதன் உரிமைகள் ,

India, Mauritius sign Comprehensive Economic Cooperation and Partnership Agreement


Economy > Trade
26 February 2021
India on Tuesday signed a Comprehensive Economic Cooperation and Partnership Agreement (CECPA) with Mauritius, which is also the first trade agreement signed by India with an African nation. 
The agreement is limited in scope, covering areas like trade in goods, rules of origin, trade in services, technical barriers to trade, sanitary and phytosanitary measures, dispute settlement, movement of natural persons, telecom, financial services, customs procedures and cooperation in other areas. 
Commerce secretary Anup Wadhawan and Ambassador Haymandoyal Dillum, secretary of foreign affairs, regional integration and international trade, Government of Mauritius signed the CECPA  in Port Louis on Monday in the presence of Prime Minister of Mauritius Pravind Jugnauth, and India’s external affairs minister S Jaishankar. ....

Pravind Jugnauth , Haymandoyal Dillum , Anup Wadhawan , Partnership Agreement , Comprehensive Economic Cooperation , Ambassador Haymandoyal Dillum , Port Louis , Prime Minister , Mauritius Pravind Jugnauth , Automatic Trigger Safeguard Mechanism , Domain B , அனுப்பி வாதவன் , விரிவான பொருளாதார ஒத்துழைப்பு , போர்த் லூயிஸ் , ப்ரைம் அமைச்சர் , தானியங்கி தூண்டுதல் பாதுகாத்தல் பொறிமுறை ,

EUSA Pharma: SYLVANT (siltuximab) Recommended by the National Comprehensive Cancer Network (NCCN) as the Preferred Treatment Option for Patients with Idiopathic Multicentric Castleman Disease (iMCD) regardless of histopathologic subtype


(1)
EUSA Pharma (UK) Limited (
EUSA Pharma ), a global biopharmaceutical company focused on oncology and rare diseases, announced that the National Comprehensive Cancer Network
(NCCN
) for B-Cell Lymphomas to include siltuximab (SYLVANT
) as the preferred primary treatment for patients with human immunodeficiency virus-negative [HIV(-)] and human herpesvirus 8-negative [HHV-8(-)] multicentric Castleman disease (MCD), also known as idiopathic multicentric Castleman disease (iMCD), regardless of histopathologic subtype.
1 Siltuximab is currently approved in more than 40 countries worldwide for the treatment of all histopathologic subtypes of iMCD, a rare, life-threatening and debilitating orphan condition of the lymph nodes and related tissues.
2,3 The update is based on a 2020 publication which demonstrated that there is insufficient evidence to guide treatment based solely on lymph node histopathologic subtype. ....

Hemel Hempstead , United Kingdom , United States , Kostenloser Wertpapierhandel , Lee Morley , David Fajgenbaum , Rebecca Kerr , National Comprehensive Cancer Network Inc , European Commission , Drug Administration , Castleman Disease Collaborative Network , Eusa Pharma United Kingdom Limited , University Of Pennsylvania , Pharma United Kingdom Ltd , National Comprehensive Cancer Network , National Comprehensive Cancer , Clinical Practice Guidelines , B Cell Lymphomas , Chief Executive Officer , Assistant Professor , Translational Medicine Human Genetics , Co Founder Executive Director , Castleman Disease Collaborative , Usage See , Product Characteristics , Practice Guidelines ,